SCHEMBL18016519

SCHEMBL18016519

C=C1NC(=O)C(CO)=CN1[C@@H]1O[C@H](CN)C(O)[C@@H]1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MTOR P42345 2/20 0.37
▸ GMNN O75496 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ DNMT1 P26358 1/20 0.37
▸ THPO P40225 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ HBB P68871 1/20 0.37
▸ PMP22 Q01453 1/20 0.37
▸ CDA P32320 6/20 0.36
▸ SLC28A1 O00337 1/20 0.36
▸ SLC28A2 O43868 1/20 0.36
▸ SLC29A1 Q99808 1/20 0.36
▸ SLC28A3 Q9HAS3 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15855025 0.88 CDA (0.36) LMNAALDH1A1MTORGMNNTP53
SCHEMBL18016515 0.85 ADORA3 (0.37) LMNAALDH1A1MTORGMNNTP53
SCHEMBL18016510 0.84 CHEK1 (0.34) LMNAALDH1A1MTORGMNNTP53
SCHEMBL14946029 0.82 P2RY2 (0.35) LMNAALDH1A1MTORGMNNTP53
SCHEMBL18118134 0.82 P2RY2 (0.35) LMNAALDH1A1MTORGMNNTP53
SCHEMBL17463529 0.82 P2RY2 (0.35) LMNAALDH1A1MTORGMNNTP53
SCHEMBL15249065 0.82 P2RY2 (0.35) LMNAALDH1A1MTORGMNNTP53
SCHEMBL14928773 0.82 P2RY2 (0.35) LMNAALDH1A1MTORGMNNTP53
SCHEMBL25458682 0.78 CDA (0.42) LMNAALDH1A1MTORGMNNTP53
SCHEMBL16478470 0.78 LMNA (0.43) LMNAALDH1A1MTORGMNNTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160237108-A1 POLYNUCLEOTIDE MOLECULES AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2016-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160237108-A1 POLYNUCLEOTIDE MOLECULES AND USES THEREOF NSUN3, POLRMT, TRDMT1 LMNA 1343/4885ALDH1A1 3790/4885MTOR 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback